Mononucleosis and Athletic Participation: An Evidence-Based Subject Review

  title={Mononucleosis and Athletic Participation: An Evidence-Based Subject Review},
  author={Margot Putukian and Francis G. O’Connor and Paul R. Stricker and Christopher McGrew and Robert G. Hosey and Steven Gordon and James J. Kinderknecht and Vesna Martich Kriss and Gregory L. Landry},
  journal={Clinical Journal of Sport Medicine},
Infectious mononucleosis (IM) is a common medical condition that afflicts thousands of young athletes each year. Despite the self-limited nature of this disorder, the variability of the clinical presentation and the rare risk of splenic rupture routinely present sports medicine clinicians with difficult return-to-play decisions. Currently there are no evidence-based guidelines regarding the management of the athlete with IM. This review discusses the available research data pertaining to the… 

Infectious Mononucleosis Management in Athletes.

Common Sports-Related Infections: A Review on Clinical Pictures, Management and Time to Return to Sports

The relationship betweenPhysical activity and immune system, characteristics of different types of infections in athletes with emphasis on special clinical presentations or complications, time to return to physical activity and training and strategies to prevent development and transmission of infections are the main topics of this review.

Return to Play After Infectious Mononucleosis

Return-to-play decisions for the athlete with infectious mononucleosis need to be individualized because of the variable disease course and lack of evidence-based guidelines.

Infectious disease.

Splenic Injuries in Athletes: A Review

The evaluation of athletes with blunt abdominal trauma for splenic injury, including the imaging, management, and current return-to-play guidelines are discussed.

Traumatic Splenic Laceration: A Rare Complication of Infectious Mononucleosis in an Athlete

A case of traumatic splenic laceration in a 19-year-old professional hockeyplayer with apreceding history of a febrile illness 2wkprior is presented.

Infectious mononucleosis

The aim of this review is to assist those who encounter infectious mononucleosis in the adolescent and adult population with appropriate patient education.

Splenomegaly from Recurrent Infectious Mononucleosis in an NCAA Division I Athlete

This unique case report features a National Collegiate Athletic Association Division I athlete with a history of remote IM infection (EBV viral capsid antigen [VCA] (+) IgG), which developed a new symptomatic IM infection with subsequent splenomegaly.

Spontaneous splenic rupture in infectious mononucleosis

Timely diagnosis and setting indications for surgical treatment are crucial in healing and patients should wait to start with sport activities at least two months if the size of the spleen is within normal range.

The Preparticipation Physical Exam

This chapter will discuss the pertinent details in performing an adequate PPE with special attention to the most common life-threatening conditions.



Infectious mononucleosis: return to play.

Infectious Mononucleosis

Among the unique clinical properties of infectious mononucleosis are prolonged and often debilitating fatigue, a high incidence of spleen enlargement and fragility, and a resultant risk for spleen

Infectious mononucleosis in athletes.

The signs and symptoms of "staleness" in an athlete, fatigue, rash, swollen glands, joint pains, poor attention span, sleep disturbances and loss of appetite, parallel remarkably those of mononucleosis.

Determination of safe return to play for athletes recovering from infectious mononucleosis: a review of the literature.

Infectious mononucleosis is an acute self-limited disorder diagnosed by clinical and hematologic measures and the decision-making process for return to play in individuals at risk for complications due to infectious monon nucleosis is reviewed.

Infectious mononucleosis in athletes.

To the Editor.— Concerning Dr. Sheehan's letter (220:864,1972), my experience with mononucleosis in the athletic community has certainly been different. In more than 30 years of observing innumerable

Infectious disease in athletes

  • T. Sevier
  • Medicine, Education
    Medical Clinics of North America
  • 1994

Infectious Mononucleosis in Active Patients

New information assesses the reliability of heterophil antibody testing and the role of EBV-specific antibody testing, and addresses issues of management, including corticosteroids, antiviral drugs, and restriction from athletic participation.

Determination of Safe Return to Play for Athletes Recovering from Infectious Mononucleosis: A Review of the Literature

  • K. WaningerH. Harcke
  • Medicine
    Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine
  • 2005
No strong evidence-based information supports use of a single parameter to predict the safe return to sports participation and current consensus supports that athletes be afebrile, well hydrated, and asymptomatic with no palpable liver or spleen.

Spontaneous splenic rupture in infectious mononucleosis: a review.

The case of a 36 year old man with infectious mononucleosis who had a spontaneous splenic rupture and who was successfully managed by splenectomy is reported.

Training Room Management of Medical Conditions: Infectious Diseases